[Form 4] Vicarious Surgical Inc. Insider Trading Activity

Rhea-AI Filing Summary

Adam David Sachs, a director, 10% owner and President of Vicarious Surgical Inc. (RBOT), reported a non-discretionary sale on 09/03/2025 of 463 shares of Class A common stock to satisfy tax-withholding obligations from restricted stock units granted on June 2, 2023. The transactions were executed as a "sell-to-cover" under the companys equity plan at a weighted average price of $5.7564 per share (trades ranged from $5.64 to $5.87). After the sale, the reporting person beneficially owned 49,164 shares directly. The Form 4 was submitted by an attorney-in-fact on 09/04/2025.

Positive

• Transaction disclosed as non-discretionary sell-to-cover to satisfy RSU tax withholding, improving transparency
• Complete price disclosure with weighted average ($5.7564) and range ($5.64$5.87), enabling clear understanding of execution

Negative

• None.

Insights

Financial Analyst

TL;DR: Small, mandatory insider sale to cover taxes; not indicative of discretionary liquidation.

The sale of 463 shares at roughly $5.76 was executed to satisfy tax withholding tied to RSU vesting and was mandated by the issuers equity plan. The size of the transaction is immaterial relative to the reporting persons remaining holding of 49,164 shares and does not signal a change in control or strategic shift. Investors should note transaction type and price range, but this Form 4 reflects routine equity-compensation mechanics rather than a voluntary insider disposition.

Corporate Governance Expert

TL;DR: Filing shows compliance with Rule 16 reporting and companys sell-to-cover policy.

The Form 4 transparently documents a tax-withholding sale tied to RSU vesting and includes disclosure of the weighted average sale price and price range. The use of an attorney-in-fact to file the Form 4 and the explanatory footnotes align with standard governance practices. There are no indications of undisclosed related-party transactions or governance irregularities in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sachs Adam David

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/03/2025		S(1)		463	D	$5.7564(2)	49,164	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

2. This figure is the weighted average sales price of multiple trades ranging from $5.64 to $5.87 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

	/s/ Erin Checka, Attorney-in-Fact	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Adam David Sachs sell according to the Form 4 for RBOT?

He sold 463 shares of Class A common stock on 09/03/2025 via a sell-to-cover transaction.

Why were the RBOT shares sold in this Form 4?

The sales were effected to cover tax withholding obligations related to RSUs granted on June 2, 2023 and were mandated by the issuers equity plan.

What price did the RBOT shares sell for?

The weighted average sales price was $5.7564 per share; individual trades ranged from $5.64 to $5.87.

How many RBOT shares does the reporting person own after the sale?

The reporting person beneficially owned 49,164 shares following the reported transaction.

Who filed the Form 4 for this RBOT transaction?

The Form 4 was signed and filed by Erin Checka, Attorney-in-Fact on 09/04/2025.